Abstract
Hyaluronic acid (HA) is a polymer with unique biological properties that has gained in interest over the years, with applications in pharmaceutical, cosmetic, and biomedical fields; however, its widespread use has been limited by its short half-life. Therefore, a new cross-linked hyaluronic acid was designed and characterized using a natural and safe cross-linking agent, such as arginine methyl ester, which provided improved resistance to enzymatic action, as compared to the corresponding linear polymer. The antibacterial profile of the new derivative was shown to be effective against S. aureus and P. acnes, making it a promising candidate for use in cosmetic formulations and skin applications. Its effect on S. pneumoniae, combined with its excellent tolerability profile on lung cells, also makes this new product suitable for applications involving the respiratory tract.
Original language | English |
---|---|
Article number | 431 |
Pages (from-to) | 1-20 |
Number of pages | 20 |
Journal | Pharmaceuticals |
Volume | 16 |
Issue number | 3 |
DOIs | |
Publication status | Published - 11 Mar 2023 |
Bibliographical note
Copyright the Author(s) 2023. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.Keywords
- hyaluronic acid
- arginine
- cross-linking
- bioactivity
- cosmeceutical
- skin
- lung